|

Preventing and Treating Thromboembolism in the 21st Century
Supplement 1 to Volume 72, April 2005 Supplement
Editor:
AMIR K. JAFFER, MD
Medical Director, IMPACT (Internal Medicine Preoperative Assessment Consultation and Treatment) Center and Anticoagulation Clinic, Section of Hospital Medicine Cleveland Clinic Foundation
Associate Editors:
DANIEL J. BROTMAN, MD, FACP
Director, Hospital Medicine Fellowship Cleveland Clinic Foundation
ALPESH N. AMIN, MD, MBA
Executive Director, Hospitalist Program Medical Director, Anticoagulation Clinic Vice Chair for Clinical Affairs Department of Medicine University of California, Irvine
|
Supplement
April
2005
Supplement
1
to Volume 72
This supplement is supported by an educational grant from AstraZeneca Pharmaceuticals LP.
This supplement was developed in print form as a certified CME activity. To complete the activity for free CME credit, please request a free print copy of the supplement by e-mailing dunaskk@ccf.org.
Guidelines
for grant-supported supplements to the Cleveland Clinic Journal
of Medicine


Education Home | CCF
Home | CCJM Home The
Cleveland Clinic Foundation
Cleveland Clinic Journal of Medicine
9500 Euclid Avenue, NA32
Cleveland, Ohio 44195
216.444.2661, FAX 216.444.9385
ccjm@ccf.org
|
|
|
CONTENTS |
  |
|
Author and Editor Disclosures  
|
|
|
Foreword  
|
|
A pharmacologic overview of current and emerging anticoagulants
Edith A. Nutescu, PharmD; Nancy L. Shapiro, PharmD; Aimee Chevalier, PharmD; and Alpesh N. Amin, MD, MBA  
|
|
|
Prevention of venous thromboembolism in medical and surgical patients
Peter J. Kaboli, MD; Adam Brenner, BS; and Andrew S. Dunn, MD |
|
Current and emerging options in the management of venous thromboembolism
Amir K. Jaffer, MD; Daniel J. Brotman, MD; and Franklin Michota, MD   |
|
|
Stroke prevention in atrial fibrillation: Current anticoagulation management and future directions
Benjamin T. Fitzgerald, MBBS; Steven L. Cohn, MD; and Allan L. Klein, MD   |
|
|
Heparin-induced thrombocytopenia: Principles for early recognition and management John R. Bartholomew, MD; Susan M. Begelman, MD; and Amjad Almahameed, MD   |
|
|
Anticoagulation in special patient populations: Are special dosing considerations required?
Franklin Michota, MD, and Geno Merli, MD   |
|
|
Cost considerations surrounding current and future anticoagulant therapies
Margaret C. Fang, MD, MPH; Tracy Minichiello, MD; and Andrew D. Auerbach, MD, MPH |
Copyright ©
2005 The Cleveland Clinic Foundation.
The statements and opinions expressed in this supplement to the Cleveland Clinic Journal of Medicine are those of the authors and not necessarily of The Cleveland Clinic Foundation, its Board of Trustees, or AstraZeneca Pharmaceuticals LP. They do not necessarily represent formal practice guidelines in effect at The Cleveland Clinic.
The
Cleveland Clinic Journal of Medicine (ISSN 0891-1150) is
published 12 times yearly by the Cleveland Clinic Foundation.
Subscription
rates: U.S. and possessions: personal $103; institutional $129;
single copy/back issue $18. Foreign: $129; single copy/back issue
$18. Institutional (multiple-reader rate) applies to libraries,
schools, hospitals, and federal, commercial, and private institutions
and organizations. Individual subscriptions must be in the names
of, billed to, and paid by individuals.
Postmaster
address changes: Cleveland Clinic Journal of Medicine, NA32,
9500 Euclid Avenue, Cleveland, OH 44195. Subscription orders,
editorial, reprint, and production offices (same address): Phone
(216) 444-2661; Fax (216) 444-9385; E-mail, ccjm@ccf.org; World
Wide Web address: http://www.ccjm.org
Printed
in USA.
|
|